Ignore this step, and you'll have clogged pores. Too often, and you’ll damage your skin. We asked dermatologists to clear things up.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Key Updates in Gastric and Esophageal Cancer Management / cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical ...